Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
McKesson
Novartis
Covington
Fish and Richardson
Accenture
Mallinckrodt
Baxter
Argus Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

ILOTYCIN Drug Profile

« Back to Dashboard

When do Ilotycin patents expire, and what generic alternatives are available?

Ilotycin is a drug marketed by Dista and is included in three NDAs.

The generic ingredient in ILOTYCIN is erythromycin gluceptate. There are one hundred and one drug master file entries for this compound. Additional details are available on the erythromycin gluceptate profile page.

US Patents and Regulatory Information for ILOTYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dista ILOTYCIN erythromycin OINTMENT;OPHTHALMIC 050368-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dista ILOTYCIN GLUCEPTATE erythromycin gluceptate INJECTABLE;INJECTION 050370-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dista ILOTYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 061910-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dista ILOTYCIN GLUCEPTATE erythromycin gluceptate INJECTABLE;INJECTION 050370-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dista ILOTYCIN GLUCEPTATE erythromycin gluceptate INJECTABLE;INJECTION 050370-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKesson
Argus Health
Cerilliant
Moodys
Johnson and Johnson
Chinese Patent Office
QuintilesIMS
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot